Patterns of colorectal cancer care in the United States and Canada: a systematic review.
暂无分享,去创建一个
J. Warren | J. Lund | K. Yabroff | Eboneé N. Butler | L. Harlan | N. Chawla | R. Yabroff | Neetu Chawla
[1] J. Guillem,et al. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. , 1998, International journal of radiation oncology, biology, physics.
[2] Mireya Diaz,et al. Failure to screen: predictors and burden of emergency colorectal cancer resection. , 2007, The American journal of managed care.
[3] S. Gallinger,et al. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.
[4] C. Earle,et al. Trends in healthcare utilization among older Americans with colorectal cancer: A retrospective database analysis , 2009, BMC health services research.
[5] J. Birkmeyer,et al. Racial disparities in late survival after rectal cancer surgery. , 2006, Journal of the American College of Surgeons.
[6] L. Påhlman. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Commentary , 2001 .
[7] A. Jemal,et al. Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.
[8] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.
[9] N. Baxter,et al. Variability in Reconstructive Procedures Following Rectal Cancer Surgery in the United States , 2010, Diseases of the colon and rectum.
[10] Deborah Schrag,et al. Building capacity to assess cancer care in the Medicaid population in New York State. , 2011, Health services research.
[11] J. Niland,et al. Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis. , 2009, Journal of the National Comprehensive Cancer Network : JNCCN.
[12] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[13] J. Wong,et al. The Use of Pelvic Radiation in Stage II Rectal Cancer: A Population-Based Analysis , 2010, The American surgeon.
[14] C. Begg,et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. , 2001, Journal of the National Cancer Institute.
[15] K. Knopf,et al. Racial differences in the receipt of bowel surveillance following potentially curative colorectal cancer surgery. , 2003, Health services research.
[16] S. Hendren,et al. Surgical Complications Are Associated With Omission of Chemotherapy for Stage III Colorectal Cancer , 2010, Diseases of the colon and rectum.
[17] P. T. Phang,et al. Practice patterns and appropriateness of rectal cancer management in , 2003 .
[18] G. Cooper,et al. Receipt of guideline‐recommended follow‐up in older colorectal cancer survivors , 2008, Cancer.
[19] E. Ossiander,et al. Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum , 2002, Cancer.
[20] Deborah Schrag,et al. The price tag on progress--chemotherapy for colorectal cancer. , 2004, The New England journal of medicine.
[21] P. Loehrer. Completion of Therapy by Medicare Patients With Stage III Colon Cancer , 2007 .
[22] E. McCarthy,et al. Dying with Cancer: Patients' Function, Symptoms, and Care Preferences as Death Approaches , 2000, Journal of the American Geriatrics Society.
[23] J. Goodwin,et al. Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer. , 2006, The oncologist.
[24] D. Schwartz,et al. Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population , 2008, Cancer.
[25] R. Cress,et al. Use of Surgical Procedures and Adjuvant Therapy in Rectal Cancer Treatment: A Population-Based Study , 2001, Annals of surgery.
[26] T. Ben-Menachem,et al. Sociodemographic Differences in the Receipt of Colorectal Cancer Surveillance Care Following Treatment With Curative Intent , 2001, Medical care.
[27] D. Rothenberger,et al. The Status of Radical Proctectomy and Sphincter-Sparing Surgery in the United States , 2007, Diseases of the colon and rectum.
[28] J. Lynn,et al. Age and gender differences in Medicare expenditures at the end of life for colorectal cancer decedents. , 2007, Journal of women's health.
[29] A. Morris,et al. Adjuvant Radiation for Rectal Cancer: Do We Measure Up to the Standard of Care? An Epidemiologic Analysis of Trends Over 25 Years in the United States , 2005, Diseases of the colon and rectum.
[30] M. Winget,et al. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004. , 2009, Clinical colorectal cancer.
[31] K. Hardiman,et al. Disparities in the treatment of colon cancer in octogenarians. , 2009, American journal of surgery.
[32] J. Warren,et al. Patterns of colorectal cancer care in Europe, Australia, and New Zealand. , 2013, Journal of the National Cancer Institute. Monographs.
[33] Xiaocheng Wu,et al. Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana. , 2004, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society.
[34] Effect of lymph node retrieval rates on the utilization of adjuvant chemotherapy in stage II colon cancer , 2009, Journal of surgical oncology.
[35] B. Minsky. Sphincter preservation in rectal cancer , 1999, International Journal of Clinical Oncology.
[36] M. Jankowski,et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. , 2005, Journal of the National Cancer Institute. Monographs.
[37] E. Feuer,et al. Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries. , 2001, Gastrointestinal endoscopy.
[38] C. Begg,et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results--Medicare. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] A. Chak,et al. Patterns of endoscopic follow-up after surgery for nonmetastatic colorectal cancer. , 2000, Gastrointestinal endoscopy.
[40] K. Kozak,et al. External beam radiotherapy for colon cancer: patterns of care. , 2010, International journal of radiation oncology, biology, physics.
[41] Karla Kerlikowske,et al. Trends in Colonoscopy for Colorectal Cancer Screening , 2007, Medical care.
[42] E. Wagner,et al. Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer. , 2004, Gastrointestinal endoscopy.
[43] T. To,et al. Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population , 2000, Journal of Gastrointestinal Surgery.
[44] J. Krischer,et al. Effects of health insurance and race on colorectal cancer treatments and outcomes. , 2000, American journal of public health.
[45] A. Neugut,et al. Survival Associated with 5-FluorouracilBased Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer , 2002, Annals of Internal Medicine.
[46] E. Lamont,et al. End‐of‐life care for older cancer patients in the Veterans Health Administration versus the private sector , 2010, Cancer.
[47] H. Au,et al. Ageism in rectal carcinoma? , 2002, International journal of gastrointestinal cancer.
[48] Laura-Mae Baldwin,et al. Residual treatment disparities after oncology referral for rectal cancer. , 2008, Journal of the National Cancer Institute.
[49] M. Winget,et al. Characteristics of patients with stage III colon adenocarcinoma who fail to receive guideline‐recommended treatment , 2010, Cancer.
[50] C. Lynch,et al. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] A. Morris,et al. Racial disparities in rectal cancer treatment: a population-based analysis. , 2004, Archives of surgery.
[52] P. Loehrer. Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly , 2007 .
[53] A. Neugut,et al. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. , 2001, Cancer journal.
[54] S. Gill,et al. Primary Tumor Resection in Patients Presenting With Metastatic Colorectal Cancer: Analysis of a Provincial Population-Based Cohort , 2010, American journal of clinical oncology.
[55] W. Barlow,et al. Explaining black-white differences in receipt of recommended colon cancer treatment. , 2005, Journal of the National Cancer Institute.
[56] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.
[57] Harry B. Spencer,et al. At the State Level , 1955 .
[58] L. Clegg,et al. Patterns of Care for Adjuvant Therapy in a Random Population-Based Sample of Patients Diagnosed with Colorectal Cancer , 2006, The American Journal of Gastroenterology.
[59] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[60] R. Single,et al. Surgical Resection of Primary Tumors in Patients Who Present With Stage IV Colorectal Cancer: An Analysis of Surveillance, Epidemiology, and End Results Data, 1988 to 2000 , 2005, Annals of Surgical Oncology.
[61] P. Stang,et al. Treatment and Referral Patterns for Colorectal Cancer , 2004, Medical care.
[62] A. Neugut,et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] G. Cooper,et al. Temporal trends in colorectal procedure use after colorectal cancer resection. , 2006, Gastrointestinal endoscopy.
[64] Charles W. Given,et al. Medicaid, Medicare, and the Michigan Tumor Registry: A Linkage Strategy , 2007, Medical decision making : an international journal of the Society for Medical Decision Making.
[65] E. Elkin,et al. Cancer's next frontier: addressing high and increasing costs. , 2010, JAMA.
[66] D. Turner,et al. Local recurrence after rectal cancer treatment in Manitoba. , 2009, Canadian journal of surgery. Journal canadien de chirurgie.
[67] C. Earle,et al. Trends in Follow-up and Preventive Care for Colorectal Cancer Survivors , 2008, Journal of General Internal Medicine.
[68] L. Temple,et al. Use of surgery among elderly patients with stage IV colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] R. Pietrobon,et al. Relationship Between Surgeon Caseload and Sphincter Preservation in Patients With Rectal Cancer , 2005, Diseases of the colon and rectum.
[70] Laura-Mae Baldwin,et al. Completion of therapy by Medicare patients with stage III colon cancer. , 2006, Journal of the National Cancer Institute.
[71] A. Stewart,et al. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. , 2005, JAMA.
[72] J. Skibber,et al. Are We Undertreating Rectal Cancer in the Elderly?: An Epidemiologic Study , 2007, Annals of surgery.
[73] Xianglin L. Du,et al. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002 , 2008, Cancer.
[74] C. Mathers,et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.
[75] R. Peto,et al. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials , 2001, The Lancet.
[76] C. Ko,et al. A Patient's Race/Ethnicity Does Not Explain the Underuse of Appropriate Adjuvant Therapy in Colorectal Cancer , 2006, Diseases of the colon and rectum.
[77] T. Fitzgerald,et al. Adjuvant chemotherapy after resection in elderly Medicare and Medicaid patients with colon cancer. , 2008, Archives of internal medicine.
[78] A. Stewart,et al. Age-, Race-, and Ethnicity-Related Differences in the Treatment of Nonmetastatic Rectal Cancer: A Patterns of Care Study From the National Cancer Data Base , 2008, Annals of Surgical Oncology.
[79] M. Pisu,et al. Less-than-standard treatment in rectal cancer patients: which patients are at risk? , 2010, Journal of the National Medical Association.
[80] E. Emanuel,et al. Chemotherapy Use among Medicare Beneficiaries at the End of Life , 2003, Annals of Internal Medicine.
[81] A. Neugut,et al. Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer. , 2009, Journal of the National Cancer Institute.
[82] R. Hilsden,et al. A retrospective study on the use of post-operative colonoscopy following potentially curative surgery for colorectal cancer in a Canadian province , 2004, BMC Cancer.
[83] G. Pond,et al. Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer. , 2008, Clinical colorectal cancer.
[84] W. Chapman,et al. Disparate outcomes in patients with colorectal cancer: effect of race on long-term survival. , 2002, Archives of surgery.
[85] A. Neugut,et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[86] Joseph Lipscomb,et al. State-Level Cancer Quality Assessment and Research: Building and Sustaining the Data Infrastructure , 2011, Cancer journal.
[87] C. Earle,et al. Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States , 2010, BMC health services research.
[88] D. Turner,et al. Survival and treatment trends of rectal cancer patients in a population with suboptimal local control. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[89] C. Becerra,et al. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer. , 2010, Clinical colorectal cancer.
[90] Xianglin L. Du,et al. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[91] J. Meza,et al. Temporal and Regional Variations in the Use of Preoperative Radiation Therapy for Rectal Cancer , 2010, American journal of clinical oncology.
[92] Ma Dong,et al. Bevacizumab plus Irinotecan,Fluorouracil,and Leucovorin for Metastatic Colorectal Cancer , 2006 .
[93] Deborah Schrag,et al. Overview of the SEER-Medicare Data: Content, Research Applications, and Generalizability to the United States Elderly Population , 2002, Medical care.
[94] A. Zaslavsky,et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[95] J. Guillem,et al. Young Age Influences Treatment but not Outcome of Colon Cancer , 2007, Annals of Surgical Oncology.
[96] E. Guadagnoli,et al. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? , 2005, Journal of the National Cancer Institute.